文献速递胸部CT

增强CT预测临床IA-IIA期肺腺癌隐匿性淋巴结转移:双中心研究

Predictability and Utility of Contrast-Enhanced CT on Occult Lymph Node Metastasis for Patients with Clinical Stage IA-IIA Lung Adenocarcinoma: A Double-Center Study.
PubMed 文献 · Acad Radiol · 2023-03-30

双中心回顾性研究纳入707例临床IA-IIA期肺腺癌患者,行肺叶切除及系统淋巴结清扫,分析增强CT征象与隐匿性淋巴结转移(OLM)的关系。

要点

  • 实性成分直径增大、支气管血管束增粗、分叶征和阻塞性改变是OLM的独立预测因素。
  • 基于增强CT的列线图模型可术前无创评估OLM风险,辅助手术决策。
  • 临床IA-IIA期肺腺癌OLM发生率约11.9%,局限手术前需警惕。

关键影像表现/征象

  • 实性成分直径较大与OLM风险升高相关(OR 2.35,95%CI 1.06-5.22,p=0.013)。
  • 支气管血管束增粗与OLM风险升高相关(OR 1.99,95%CI 1.00-3.95,p=0.049)。
  • 分叶征与OLM风险升高相关(OR 2.92,95%CI 1.22-6.99,p=0.016)。
  • 阻塞性改变与OLM风险升高相关(OR 1.69,95%CI 1.17-6.16,p=0.020)。

诊断标准与关键数值

  • 训练组模型AUC为0.821(95%CI 0.775-0.853),验证组AUC为0.788(95%CI 0.732-0.806)。
  • 模型校准良好(Hosmer-Lemeshow拟合优度检验p=0.816)。

临床应用与阅片要点

  • 阅片时需关注实性成分直径、支气管血管束增粗、分叶征及阻塞性改变,综合评估OLM风险。
  • 对高风险患者,应提示外科谨慎选择局限手术,避免遗漏隐匿性淋巴结转移。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: With the advantage of minimizing damage and preserving more functional lung tissue, limited surgery is considered depend on the lymph node (LN) involvement situation. However, occult lymph node metastasis (OLM) may be ignored by limited surgery and become a risk factor for local recurrence after surgical resection. The aim of this study was to assess the risk factors for OLM based on computed tomography enhanced image in patients with clinical lung adenocarcinoma (ADC).

MATERIALS AND METHODS: From January 2016 to July 2022, 707 patients with clinical stage IA-IIA ADC underwent lobectomy with systematic LN dissection and were divided into training and validation group based on different institution. Univariate analysis followed by multivariable logistic regression were performed to estimate different risk factors of OLM. A predictive model was established with visual nomogram and external validation, and evaluated in terms of accuracy, sensitivity, specificity, and area under the receiver operating characteristic curve (AUC).

RESULTS: Fifty-nine patients were diagnosed with OLM (11.9%), and four independent predictors of LN involvement were identified: larger consolidation diameter (odds ratio [OR], 2.35, 95% confidence interval [CI]: 1.06, 5.22, p = 0.013), bronchovascular bundle thickening (OR, 1.99, 95% CI: 1.00, 3.95, p = 0.049), lobulation (OR, 2.92, 95% CI: 1.22, 6.99, p = 0.016) and obstructive change (OR, 1.69, 95% CI: 1.17, 6.16, p = 0.020). The model showed good calibration (Hosmer-Lemeshow goodness-of-fit, p = 0.816) with an AUC of 0.821 (95% CI: 0.775, 0.853). For the validation group, the AUC was 0.788 (95% CI: 0.732, 0.806).

CONCLUSION: Our predictive model can non-invasively assess the risk of OLM in patients with clinical stage IA-IIA ADC, enable surgeons perform an individualized prediction preoperatively, and assist the clinical decision-making procedure.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Zhao, Zhao, Zhang, et al. Predictability and Utility of Contrast-Enhanced CT on Occult Lymph Node Metastasis for Patients with Clinical Stage IA-IIA Lung Adenocarcinoma: A Double-Center Study. Acad Radiol. 2023. PMID: 37003873. doi:10.1016/j.acra.2023.03.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。